Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared

Rina Mina1, Hermine I Brunner

  • 1Division of Rheumatology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MC 4010, Cincinnati, OH 45229, USA.

Insights

Pediatric systemic lupus erythematosus (SLE) presents more acutely with higher mortality and organ damage compared to adult SLE. Unique pathways explaining these differences in pediatric lupus remain elusive.

Area of Science:

  • Rheumatology
  • Immunology
  • Pediatric Medicine

Background:

  • Complement deficiencies are linked to early-onset systemic lupus erythematosus (SLE).
  • Significant variability exists in SLE disease phenotypes, particularly between pediatric and adult patients.
  • The underlying physiological and genetic factors driving these phenotypic differences are not well understood.

Purpose of the Study:

  • To highlight the distinct clinical presentation and outcomes of pediatric SLE compared to adult SLE.
  • To underscore the need for further research into the unique pathways influencing pediatric SLE.

Main Methods:

  • Comparative analysis of clinical data from pediatric and adult SLE patients.
  • Review of existing literature on SLE pathophysiology and treatment.

Main Results:

  • Children with SLE exhibit more acute illness, with greater frequency of renal, hematologic, and central nervous system involvement.
  • Pediatric SLE patients have higher mortality rates and accrue more organ damage (renal, ocular, musculoskeletal) than adults.
  • Adult SLE patients experience higher rates of cardiovascular mortality.

Conclusions:

  • Pediatric SLE is a distinct clinical entity with more severe manifestations and poorer outcomes compared to adult SLE.
  • Current understanding of SLE pathophysiology does not fully explain the observed differences in disease presentation and progression between age groups.
  • Further investigation into unique pediatric SLE pathways is crucial for improving patient care and outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...